To understand if FERMT2 is involved in modulating the tumor immune microenvironment in CRC, the association of FERMT2 expression with the profiles of immune cell infiltration were investigated in CRC using TIMER database. This evidence concerns the gene FERMT2 and colorectal carcinoma.